In research involving both mice and humans, a genetically-engineered medication was found to replenish the levels of a critical protein, thereby preserving the function of motor neurons. This breakthrough, specifically relevant to amyotrophic lateral sclerosis where this function is typically compro
In nearly all cases of amyotrophic lateral sclerosis and in as many as half of alldisease and frontotemporal dementia incidents, a protein known as TDP-43 is misplaced from its usual position in the cell’s nucleus.
This displacement results in the loss of stathmin-2, a protein that is vital for the regeneration of neurons and the preservation of their links to muscle fibers, both of which are essential for muscle contraction and movement., a group of researchers, led by Don Cleveland, Ph.D., who is a Distinguished Professor of Medicine, Neurosciences, and Cellular and Molecular Medicine at theDNA“With mouse models, we engineered to misprocess their stathmin-2 encoding RNAs, like in these human diseases, we show that administration of one of these designer DNA drugs into the fluid that surrounds the brain and spinal cord restores normal stathmin-2 levels throughout the nervous system,” Cleveland said. Don Cleveland, Ph.D., Distinguished Professor of Medicine, Neurosciences, and Cellular and Molecular Medicine at UC San Diego School of Medicine, is among the most highly cited researchers in the world for his work investigating neurodegenerative diseases. Credit: Erik Jepsen, UC San Diego Cleveland is broadly credited with developing the concept of designer DNA drugs, which act to either turn on or turn off genes associated with many degenerative diseases of the aging human nervous system, including ALS, AD, Huntington’s disease, and cancer. Several designer DNA drugs are currently in clinical trials for multiple diseases. One such drug has been approved to treat a childhood neurodegenerative disease called spinal muscular atrophy. The new study builds upon ongoing research by Cleveland and others regarding the role and loss of TDP-43, a protein associated with ALS, AD, and other neurodegenerative disorders. In ALS, TDP-43 loss impacts the motor neurons that innervate and trigger the contraction of skeletal muscles, causing them to degenerate, eventually resulting in paralysis. “In almost all instances of ALS, there is aggregation of TDP-43, a protein that functions in maturation of the RNA intermediates that encode many proteins. Reduced TDP-43 activity causes misassembly of the RNA-encoding stathmin-2, a protein required for maintenance of the connection of motor neurons to muscle,” said Cleveland. “Without stathmin-2, motor neurons disconnect from muscle, driving paralysis that is characteristic of ALS. What we have now found is that we can mimic TDP-43 function with a designer DNA drug, thereby restoring correct stathmin-2 RNA and protein level in the mammalian nervous system.” Specifically, the researchers edited genes in mice to contain human STMN2 gene sequences and then injected antisense oligonucleotides — small bits of DNA or RNA that can bind to specific RNA molecules, blocking their ability to make a protein or changing how their final RNAs are assembled — into cerebral spinal fluid. The injections corrected STMN2 pre-mRNA misprocessing and restored stathmin-2 protein expression fully independent of TDP-43 function. “Our findings lay the foundation for a clinical trial to delay paralysis in ALS by maintaining stathmin-2 protein levels in patients using our designer DNA drug,” Cleveland said.cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies” by Michael W. Baughn, Ze’ev Melamed, Jone López-Erauskin, Melinda S. Beccari, Karen Ling, Aamir Zuberi, Maximilliano Presa, Elena Gonzalo-Gil, Roy Maimon, Sonia Vazquez-Sanchez, Som Chaturvedi, Mariana Bravo-Hernández, Vanessa Taupin, Stephen Moore, Jonathan W. Artates, Eitan Acks, I. Sandra Ndayambaje, Ana R. Agra de Almeida Quadros, Paayman Jafar-nejad, Frank Rigo, C. Frank Bennett, Cathleen Lutz, Clotilde Lagier-Tourenne and Don W. Cleveland, 16 March 2023,
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Starbucks’ New Summer Menu Is Here: We Asked Nutritionists If the New Drinks Are HealthyThe Chocolate Java Mint Frappuccino and White Chocolate Macadamia Cream Cold Brew aren’t exactly health drinks.
Read more »
Breakthrough kidney stone procedure called 'game changer' for patientsIt's being called an absolute game changer: a groundbreaking procedure to get rid of painful stones while patients are awake, no anesthesia needed.
Read more »
Madeline Kenney Announces New Album A New Reality MindOakland singer/songwriter Madeline Kenney (mkenneymusic) has announced her fourth album, 'A New Reality Mind,' out July 28 via carparkrecords. Listen to lead single 'Superficial Conversation' here:
Read more »
Venom's Blockchain Breakthrough: Weaving a New Digital Dawn for Africa | HackerNoonBlockchain technology has the potential to usher in a new age of frictionless international commerce, lowering transaction costs and accelerating development. - web3 africa
Read more »
New bill would require background checks and registration for migrants in New York StateALBANY – A new bill seeking to get a handle on New York’s growing migrant crisis would require state officials to vet and monitor migrants sent to New York from the U.S. Southern Border. Asse…
Read more »
New York couple opens new Asian-fusion restaurant Tangra’s Daughter in Missouri CityTangra’s Daughter, a restaurant serving Indo-Chinese cuisine has opened in Missouri...
Read more »